Kristi Zentner and Heather Marx, attorneys in the Customs, Imports & Trade Remedies Practice Group of Cozen O’Connor, discuss how the recommendations of Biden’s supply chain task force might lead to real progress toward the return of domestic manufacturing of critical supplies.

Suresh Acharya, Professor of Practice in the Robert H. Smith School of Business at the University of Maryland, addresses the excess of COVID-19 vaccine doses in the U.S., and what to do about it.

Despite its success in rushing COVID-19 vaccines to market, the biopharmaceutical supply chain is far from perfect.

Bert Burger, economist and resident expert on India with Atradius, details the state of that country’s struggle to contain the COVID-19 virus.